0 reactions
indianmarketgrid The RNA-medicine developer priced an expanded 26.3-million-share offering at the top of its range, signalling resilient demand for selected healthcare listings.
READ FULL ANALYSIS MEMBER ANALYSIS
THE IMG COMMUNITY
Market insights. Fresh perspectives. Your conversation.
indianmarketgrid The RNA-medicine developer priced an expanded 26.3-million-share offering at the top of its range, signalling resilient demand for selected healthcare listings.